Mari Lahnalampi

Kuopio, 70211, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Genomic determinants of therapy response in ETV6::RUNX1 leukemia.

Genomic determinants of therapy response in ETV6::RUNX1 leukemia.

Journal: Leukemia
Published: September 16, 2024

MicroRNA gene dynamics in immune cell subpopulations during aging and atherosclerosis disease development at single-cell resolution.

MicroRNA gene dynamics in immune cell subpopulations during aging and atherosclerosis disease development at single-cell resolution.

Journal: Genome medicine
Published: September 09, 2024

Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivo.

Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivo.

Journal: Leukemia
Published: July 05, 2024

Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure.

Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure.

Journal: HemaSphere
Published: December 30, 2023

Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL.

Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL.

Journal: Blood advances
Published: September 05, 2023

Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia.

Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia.

Journal: Genome biology
Published: May 15, 2023

In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution.

In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution.

Journal: Cell genomics
Published: March 10, 2022

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.

Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse.

Journal: Nature communications
Published: April 01, 2021

SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.

SIX6 is a TAL1-regulated transcription factor in T-ALL and associated with inferior outcome.

Journal: Leukemia & lymphoma
Published: August 25, 2020

Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.

Single cell characterization of B-lymphoid differentiation and leukemic cell states during chemotherapy in ETV6-RUNX1-positive pediatric leukemia identifies drug-targetable transcription factor activities.

Journal: Genome medicine
Published: May 07, 2020
Showing 1-10 of 10

Last Updated: 09/26/2026